Effect of Dapagliflozin in Patients with Diabetes and Heart Failure with Mildly Reduced or Preserved Ejection Fraction According to Background Glucose-Lowering Therapy: A Pre-Specified Analysis of the DELIVER Trial

Mats Christian Højbjerg Lassen, Muthiah Vaduganathan, Kieran F. Docherty et al.|European Journal of Heart Failure|2024

Cited by 11